ISU Abxis Company is Pharmaceuticals in South Korea that focus on therapeutic antibodies business. Founded in 2001. They cover business area such as ISU Abxis Co.Ltd., therapeutic antibody, South Korea, Abciximab, Clotinab, Abcertin, Fabagal, incurable disease, cancer, rare disease.
2001
( 23 years old in 2024 )
Therapeutic Antibodies
-
5th floor, Global R&D Center Building C
22 Daewangpangyoro 712-beongil, Bundang-gu
Seongnam, Gyeonggi 13488
South Korea
Private
ISU Abxis Co.Ltd.therapeutic antibodySouth KoreaAbciximabClotinabAbcertinFabagalincurable diseasecancerrare disease
* We use standard office opening hours in near ISU Abxis Company's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
ISU Abxis Company is Pharmaceuticals business from South Korea that founded in 2001 (23 years old in 2024), ISU Abxis Company business is focusing on Therapeutic Antibodies.
ISU Abxis Company headquarter office and corporate office address is located in 5th floor, Global R&D Center Building C 22 Daewangpangyoro 712-beongil, Bundang-gu Seongnam, Gyeonggi 13488 South Korea.
ISU Abxis Company was founded in South Korea.
In 2024, ISU Abxis Company is currently focus on therapeutic antibodies sector.
Above is snippet of Google Trends for "therapeutic antibodies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with ISU Abxis Company, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
